Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications for innovative basic and translational research projects examining HIV infection, persistence, and comorbidities as they relate to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR) in NOT-OD-15-137: NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding.   


  • R21 Due Dates: Feb. 16, Jun. 16, Oct. 16
  • AIDS Due Date(s): Jan. 7, May 7, Sep. 7

PA-18-615 Expiration Date January 8, 2021

Agency Website



Amount Description

The combined budget for direct costs for the two-year project period may not exceed $275,000, exclusive of any consortium F&A costs per year. No more than $200,000 may be requested in any single year.

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 16, 2020